These authors concluded that MRPL12, MRPL13, and POP1 might act as oncogenes in maintaining cellular viability and stimulating the metastasis of breast cancer cells, involving the possibility of their being designed as biomarkers and/or therapeutic targets for breast cancer. This evidence concerns the gene MRPL12 and breast carcinoma.